Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Poseida Therapeutics
4380
Poseida Therapeutics
Health Care
Technology
Biotechnology
Medical
Therapeutics
Poseida Therapeutics is translating bestinclass gene editing technologies into lifesaving treatments and developing CAR Tcell immunotherapies for cancer
Suggest edits
Type
B2c
Founded
2014
Raised
$282.5M
Follow us
Also headquartered in San Diego
Qualcomm
Dan
Intuit
Edge
GoFundMe
Industry
Illumina
TuSimple
Bandsintown
Satechi
Companies in the same industry
GRO Biosciences
Casma Therapeutics
Cidara Therapeutics
Finch Therapeutics Group
Prevail Therapeutics
GenEdit Inc
Ovid Therapeutics
Click Therapeutics
Biofourmis
Hookipa Pharma
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Latest funding
Show all
$110,000,000
Venture capital (Series D) - 2020
Adage Capital Management
LLC
Schonfeld Strategic Advisors
+1
$142,000,000
Venture capital (Series C) - 2019
Aisling Capital
Novartis
Perceptive Advisors
+6
Team Size
1–10
Employees
I work here
Location
San Diego
,
United States
Headquarters
Explore San Diego
Pulse 2.0
Poseida Therapeutics (PSTX) Stock: Why It Surged 85.6%
$110,000,000
Venture capital (Series D)
FinSMEs
Poseida Therapeutics Raises $110M in Series D Financing
$30,500,000
Venture capital (Series B)
PE HUB
,
FinSMEs
,
Venture Funding News
Poseida Therapeutics snags $30.5 mln Series B
Messaging
